Pharmacogenomics of schizophrenia: Towards personalized psychiatry
- 16 September 2003
- journal article
- editorial
- Published by Wiley in Drug Development Research
- Vol. 60 (2) , 71-74
- https://doi.org/10.1002/ddr.10286
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Polymorphisms at the G72/G30 Gene Locus, on 13q33, Are Associated with Bipolar Disorder in Two Independent Pedigree Series*American Journal of Human Genetics, 2003
- Deconstructing SchizophreniaScience, 2003
- Identification of a novel variant of the human NR2B gene promoter region and its possible association with schizophreniaMolecular Psychiatry, 2002
- Genetic and physiological data implicating the new human gene G72 and the gene for d -amino acid oxidase in schizophreniaProceedings of the National Academy of Sciences, 2002
- Neuregulin 1 and Susceptibility to SchizophreniaAmerican Journal of Human Genetics, 2002
- Glutamatergic Mechanisms in SchizophreniaAnnual Review of Pharmacology and Toxicology, 2002
- Novel Neurotransmitters and Their Neuropsychiatric RelevanceAmerican Journal of Psychiatry, 2000
- Muscarinic M1 agonists in the treatment of Alzheimer’s diseaseExpert Opinion on Investigational Drugs, 2000
- Crystal structure of D-amino acid oxidase: a case of active site mirror-image convergent evolution with flavocytochrome b2.Proceedings of the National Academy of Sciences, 1996
- d-Cycloserine adjuvant therapy to conventional neuroleptic treatment in schizophrenia: an open-label studyJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1994